Gilead Sciences, Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Gilead Sciences, Inc. (GILD) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Gilead Sciences, Inc. clearly outscores UnitedHealth Group Incorporated on Q·Score (8.2 vs 6.1 out of 10), led by Quality (9.6 vs 5.9) and Growth (7.9 vs 5.1). UnitedHealth Group Incorporated scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for GILD (+25.5%) than for UNH (-0.3%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 43% return on equity and 31% profit margins.
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
GILD vs UNH: which stock scores better overall?
Based on Q·Score, Gilead Sciences, Inc. (GILD) scores 8.2/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: GILD or UNH?
Gilead Sciences, Inc. (GILD) scores higher on Growth (7.9/10 vs 5.1/10). Gilead Sciences, Inc. reports revenue growth (4.4% YoY) while UnitedHealth Group Incorporated reports (2.0% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is GILD or UNH more attractively valued?
Gilead Sciences, Inc. (GILD) scores higher on Valuation (7.7/10 vs 6.5/10). GILD trades at 13.0× P/E versus UNH at 19.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about GILD vs UNH?
There are 28 analysts covering GILD with a consensus price target of $157.57, and 26 analysts covering UNH with a consensus target of $407.38. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: GILD or UNH?
Gilead Sciences, Inc. (GILD) scores higher on Quality (9.6/10 vs 5.9/10). Net profit margin: GILD at 31.0%, UNH at 2.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: GILD or UNH?
Gilead Sciences, Inc. (GILD) scores higher on Financial Health (7.6/10 vs 5.3/10). Market beta: GILD at 0.33, UNH at 0.65. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of GILD and UNH?
Gilead Sciences, Inc. (GILD) has a market capitalisation of $155.9B, while UnitedHealth Group Incorporated (UNH) has a market cap of $371.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do GILD or UNH pay dividends?
GILD pays a dividend yield of 2.61%, while UNH pays a dividend yield of 2.27%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →